Reuters is reporting that ahead of this weekend’s G20 summit in Turkey, Petra Wilson, head of the International Diabetes Federation, is calling on world leaders to take collective action against diabetes, which can be attributed to a death every six seconds, by taxing sugar in a manner similar to that around alcohol and tobacco. “It is very well established that heavy taxation on tobacco and relentless reinforcement of the message that tobacco is unhealthy has had a very good effect,” she told Reuters. “It is time now we adopted a similar approach with sugar.” (Reuters)
Shoppers hear, “It may help prevent diarrhea,” so they make the purchase. What they seldom understand is that probiotics are much more than just a diarrhea preventive. In fact, probiotics can be found in the ears, nose, mouth, lungs, urinary tract and more, and are linked to overall health, not just gastrointestinal health.
Skyn Condoms, a brand of Ansell Healthcare, is partnering with the Movember Foundation this month with a special “Movember Edition box.” Drug Store News spoke with Carol Carrozza, Ansell VP sales and marketing at TSE. Here’s what she had to say.
Birth rates are on the rise, according to the latest report from the Centers for Disease Control and Prevention. That’s good news for sellers of family planning test kits — overall sales of both pregnancy and ovulation test kits were up 2.2% to $364.8 million across total U.S. multi-outlets for the 52 weeks ended Sept. 6, according to IRI.
A new, dynamic diabetes-centric set co-created by Johnson & Johnson and Wakefern has the potential to generate $1,000 in incremental dollars for every new diabetes customer captured by Wakerfern’s ShopRite stores, the companies revealed recently at the GMDC Health Beauty Wellness 2015 conference in Phoenix.
As 2015 draws to a close, the year is on track to be one in which the value of the branded drugs losing their patent protection approaches an all-time high. The dozens of drugs that will have lost their patent protection this year are estimated to have global sales of $44 billion a year — the highest total since $53 billion worth of medications went off patent in 2012.
Consider this: 1-in-5 hospital patients end up back in the hospital within 30 days of their discharge. And the biggest factors pulling them back all have to do with medications — either through medication errors, nonadherence or adverse drug events.
As health care continues to shift to an evidence-based model, ensuring patients are on the right therapy is a critical part of delivering improved health outcomes. Enter MD Labs and the company’s RxIGHT Pharmacogenetic test,
The New York Times is reporting that enrollment in health exchanges isn’t expected to grow much next year above current levels. “After an elaborate analysis of demographic data, Sylvia Mathews Burwell, the secretary of health and human services, said that 10 million people were expected to have marketplace coverage at the end of next year, up only about 100,000 from recent levels and millions short of earlier projections,” the report says. (The New York Times)